Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy

BACKGROUND: Dermatologic toxicity is an important adverse effect of immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death 1 receptor (PD-1) or PD ligand 1 (PD-L1). Skin toxicity most commonly includes a maculopapular erythematous rash a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Immunother Cancer
Glavni autori: Koelzer, Viktor H., Buser, Tobias, Willi, Niels, Rothschild, Sacha I., Wicki, Andreas, Schiller, Peter, Cathomas, Gieri, Zippelius, Alfred, Mertz, Kirsten D.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4986338/
https://ncbi.nlm.nih.gov/pubmed/27532022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-016-0151-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items